Found 865 articles for: "acne"
Tazarotene versus Tazarotene plus Clindamycin/Benzoyl Peroxide in the Treatment of Acne Vulgaris: A Multicenter, Double-Blind, Randomized, Parallel-Group Trial
March 2006 | Volume 5 | Issue 3 | Original Article | 256 | Copyright © March 2006
Topical retinoids offer highly effective treatment for both inflammatory and non-inflammatory acne, with tazarotene demonstrating greater efficacy than other topical retinoids. A multicenter, double-...
Long-Pulsed Dye Laser-Mediated Photodynamic Therapy Combined with Topical Therapy for Mild to Severe Comedonal, Inflammatory, or Cystic Acne
January 2006 | Volume 5 | Issue 1 | Original Article | 45 | Copyright © January 2006
Background: Acne patients who fail to respond to conventional treatments have been treated with isotretinoin, an effective treatment coming under strict regulation due to the risk of significant side...
January 2006 | Volume 5 | Issue 1 | Original Article | 35 | Copyright © January 2006
Acne rosacea is a multifactorial, somewhat mercurial disorder that can be a challenge to control with standard pharmacologic agents. Laser and light sources have been increasingly utilized, particula...
Fractionated Delivery Systems for Difficult to Treat Clinical Applications: Acne Scarring, Melasma, Atrophic Scarring, Striae Distensae, and Deep Rhytides
November 2007 | Volume 6 | Issue 11 | Original Article | 1120 | Copyright © November 2007
Fractional resurfacing or laser therapy (FLT) represents a technology that seeks to address the limitations of both ablative resurfacing and nonablative treatments. Many companies now offer versions ...
Dapsone Gel 5% for the Treatment of Acne Vulgaris: Safety and Efficacy of Long-Term (1 Year) Treatment
October 2007 | Volume 6 | Issue 10 | Original Article | 981 | Copyright © October 2007
Dapsone gel 5%, a topical formulation of dapsone, was shown to deliver clinically effective doses of dapsone with minimal systemic absorption in 2 randomized, vehicle-controlled, 12-week studies of p...
Long-Term Safety and Efficacy of a Unique Fixed-Dose Combination Gel of Adapalene 0.1% and Benzoyl Peroxide 2.5% for the Treatment of Acne Vulgaris
September 2007 | Volume 6 | Issue 9 | Original Article | 899 | Copyright © September 2007
Background: A unique, once-daily, fixed-dose combination gel with adapalene 0.1% and benzoyl peroxide (BP) 2.5% has been developed for the treatment of acne vulgaris. Objective: To evaluate the long...
September 2007 | Volume 6 | Issue 9 | Original Article | 873 | Copyright © September 2007
Acne vulgaris is an extremely common disorder affecting many adolescents and adults throughout their lifetimes. The pathogenesis of acne is multifactorial and is thought to involve excess sebum, foll...
September 2004 | Volume 3 | Issue 5 | Case Reports | 569 | Copyright © September 2004
Many medications have been reported to induce acneiform eruptions. A relatively new chemotherapy drug, gefitinib (Iressa), approved by the Food and Drug Administration in 2003 for the treatment of ad...
March 2004 | Volume 3 | Issue 2 | Original Article | 179 | Copyright © March 2004
Isotretinoin therapy for the treatment of severe nodulocystic acne has been used for the last twenty-three years. Its use has been associated with many restrictions to the patient, with some of these...
March 2004 | Volume 3 | Issue 2 | Original Article | 146 | Copyright © March 2004
The agents most commonly used in combination for the management of acne include topical retinoids and antibiotics. Topical retinoids normalize desquamation of the follicular epithelium, whereas antib...
A Single-Center Study of Aminolevulinic Acid and 417 nm Photodynamic Therapy in the Treatment of Modrate to Severe Acne Vulgaris
August 2003 | Volume 2 | Issue 4 | Original Article | 393 | Copyright © August 2003
This article describes a single-center trial involving twenty-two patients with acne vulgaris. Blu-U light was used in all patients, while half were pre-treated with aminolevulinic acid. Preliminary ...
September 2002 | Volume 1 | Issue 2 | Original Article | 153 | Copyright © September 2002
Topical acne therapies are widely used for the treatment of mild to moderately severe acne vulgaris. However, many available treatments have limitations associated with their use, including lengthy ti...
July 2004 | Volume 3 | Issue 4 | Department | 5 | Copyright © July 2004
A New Approach to Comparing Efficacy Results from Clinical Trials of Topical Acne Vulgaris Treatments
July 2007 | Volume 6 | Issue 7 | Original Article | 688 | Copyright © July 2007
Clinicians must evaluate a voluminous amount of information from clinical trials when choosing among the growing number of topical acne treatments. This article describes a simple way to evaluate and...
August 2007 | Volume 6 | Issue 8 | Case Reports | 838 | Copyright © August 2007
Acne vulgaris is the most common skin disease treated by physicians. Current topical and oral treatments may have shortand long-term negative consequences. Since radiofrequency (RF) energy has been s...
August 2007 | Volume 6 | Issue 8 | Original Article | 810 | Copyright © August 2007
Topical therapies are effective in managing acne vulgaris but are associated with local adverse effects such as irritation and dryness. This 4-week pilot study compared skin hydration in 36 healthy a...
A Comparative Review of the Efficacy and Tolerability of Retinoid-Containing Combination Regimens for the Treatment of Acne Vulgaris
June 2007 | Volume 6 | Issue 6 | Original Article | 625 | Copyright © June 2007
Many physicians regularly prescribe combination therapy involving a retinoid for their acne patients. The most common retinoid-containing regimens include either oral antibiotics or topical benzoyl p...
Study Results of Benzoyl Peroxide 5%/Clindamycin 1% Topical Gel, Adapalene 0.1% Gel and Use in Combination for Acne Vulgaris
June 2007 | Volume 6 | Issue 6 | Original Article | 616 | Copyright © June 2007
Combination therapy is the standard of care in the management of acne vulgaris. It is essential to treat as many aspects of acne pathogenesis as possible. Due to increasing insensitivity of Propi...
Clinical Safety and Efficacy Studies of a Novel Formulation Combining 1.2% Clindamycin Phosphate and 0.025% Tretinoin and for the Treatment of Acne Vulgaris
June 2007 | Volume 6 | Issue 6 | Original Article | 607 | Copyright © June 2007
Clindamycin phosphate 1.2% and tretinoin 0.025% gel (CLIN/RA gel [ZIANA™ Gel]) is a novel topical combination agent approved by the FDA for the treatment of acne vulgaris in patients 12 years of ag...
June 2007 | Volume 6 | Issue 6 | Original Article | 597 | Copyright © June 2007
Data is very limited on the demographics, epidemiology, grading, and management of truncal acne vulgaris. In this study completed in 5 cities across the US, 696 patients were assessed to evaluate the...